• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS21
Device Problem Device Dislodged or Dislocated (2923)
Patient Problems Aortic Valve Stenosis (1717); Mitral Regurgitation (1964)
Event Type  Injury  
Manufacturer Narrative
Based on the information provided, the device was ultimately implanted successfully.The event was attributed to a procedural error, and there was no evidence to suggest a problem with the device.As such, no device deficiency is suspected and no investigation is warranted.It was reported that the event was attributable to inadvertent traction on the atrial retractor during the mitral re-repair.As reported in the perceval ifu, "in case of concomitant procedures these must be performed as much as possible prior to perceval s implantation.After perceval s implantation, manipulation of the heart and/or of the ascending aorta, if required, should be done gently; should an atrial retractor be placed, take care not to compress the ascending aorta.These maneuvers may lead to unknown effects on the implanted valve, including displacement and folding." thus, the reported event is clearly identified in the perceval instructions for use, and is a known, inherent risk of the procedure.The event was reported in a conservative manner due to the involvement of the device in the event, and the potential for patient harm.However, no device deficiency or inadequacy of the ifu has been identified, and the event is attributable to procedural error.Device still implanted.
 
Event Description
The manufacturer was notified of the following event via a journal article titled "intraoperative displacement of a perceval sutureless prosthesis" (authors: falcetta, pascarella, bertini, pratali, bortolotti).It was reported that a mitral valve repair was performed concomitantly with an aortic valve replacement in which a perceval valve was implanted.After weaning from bypass, residual mitral regurgitation was identified due to inadequacy of the repair, and repeated mitral repair was required.During the second attempt at mitral repair, the perceval was displaced.The displacement was identified after weaning from bypass, and attribute to inadvertent traction on the atrial retractor during the mitral re-repair.The perceval valve was therefore removed, recollapsed and reimplanted.It was reported that the patient recovered uneventfully, with a stable mitral repair and normal functioning of the perceval prosthesis two months post-operatively.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
LIVANOVA CANADA CORP
5005 north fraser way
burnaby, bc V5J5M 1
CA  V5J5M1
Manufacturer (Section G)
LIVANOVA CANADA CORP
5005 north fraser way
burnaby, bc V5J5M 1
CA   V5J5M1
Manufacturer Contact
francesca crovato
5005 north fraser way
burnaby, bc V5J5M-1
CA   V5J5M1
MDR Report Key7636397
MDR Text Key112273356
Report Number3005687633-2018-00171
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 06/25/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model NumberPVS21
Device Catalogue NumberICV1208
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/05/2018
Initial Date FDA Received06/25/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age83 YR
-
-